Related Experiment Video
Updated: Jul 4, 2025
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
Published on: January 22, 2014
Selection of suitable reference genes for gene expression studies in HMC3 cell line by quantitative real-time RT-PCR
Martina Fazzina1, Matteo Bergonzoni2, Francesca Massenzio2
1Department for Life Quality Studies - QUVI, University of Bologna, Rimini, Italy.
Abstract:
Microglia represent the primary immune defense system within the central nervous system and play a role in the inflammatory processes occurring in numerous disorders, such as Parkinson's disease (PD). PD onset and progression are associated with factors considered possible causes of neuroinflammation, i.e. genetic mutations. In vitro models of microglial cells were established to identify specific molecular targets in PD through the analysis of gene expression data. Recently, the Human Microglial Clone 3 cell line (HMC3) has been characterized and a new human microglia model has emerged. Here we perform RT-qPCR analyses to evaluate the expression of ten reference genes in HMC3, untreated or stimulated to a pro-inflammatory status. The comparative ∆CT method, BestKeeper, Normfinder, geNorm and RefFinder algorithms were used to assess the stability of the candidate genes. The results showed that the most suitable internal controls are HPRT1, RPS18 and B2M genes. In addition, the most stable and unstable reference genes were used to normalize the expression of a gene of interest in HMC3, resulting in a difference in the statistical significance in cells treated with Rotenone. This is the first reference gene validation study in HMC3 cell line in pro-inflammatory status and can contribute to more reliable gene expression analysis in the field of neurodegenerative and neuroinflammatory research.
Insights
This study validates reference genes for accurate gene expression analysis in Human Microglial Clone 3 (HMC3) cells, crucial for Parkinson
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Microglia are key immune cells in the central nervous system, implicated in neuroinflammation and diseases like Parkinson's disease (PD).
- Accurate gene expression analysis in microglial models is vital for understanding PD pathogenesis and identifying therapeutic targets.
- The Human Microglial Clone 3 (HMC3) cell line offers a valuable in vitro model for studying human microglia.
Purpose of the Study:
- To identify stable reference genes for quantitative RT-qPCR in HMC3 cells under both normal and pro-inflammatory conditions.
- To assess the impact of reference gene selection on the statistical significance of gene expression results in a PD-relevant context (Rotenone treatment).
Main Methods:
- Quantitative RT-qPCR was used to analyze the expression of ten candidate reference genes in HMC3 cells.
- Multiple algorithms (∆CT method, BestKeeper, Normfinder, geNorm, RefFinder) were employed to evaluate gene stability.
- The most and least stable genes were used to normalize a gene of interest, comparing results.
Main Results:
- HPRT1, RPS18, and B2M were identified as the most stable reference genes in HMC3 cells under pro-inflammatory stimulation.
- The selection of reference genes significantly influenced the statistical significance of gene expression changes, particularly after Rotenone treatment.
Conclusions:
- This study provides the first reference gene validation for HMC3 cells in a pro-inflammatory state, establishing HPRT1, RPS18, and B2M as reliable internal controls.
- Utilizing these validated reference genes will enhance the reliability and reproducibility of gene expression studies in neuroinflammation and neurodegenerative research, including Parkinson's disease.
